Clinical Trials Browser

Phase 3 × Uveal Melanoma × 90 days × Clear all

NCT07015190 2026-05-06

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Phase 3 Recruiting

Uveal Melanoma, Melanoma